Proxy Votes Now

Home › Funds › Brighthouse › SA Columbia Focused Value Portfolio

SA Columbia Focused Value Portfolio proxy voting record 2025-2026

Fund family: Brighthouse · Filed by SEASONS SERIES TRUST (CIK 1003239) · SEC series S000008047

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 478 with, 21 against, 26 abstentions (not counted as with management). Shareholder proposals: 13 FOR, 8 AGAINST, 26 abstained, by the filing’s own vote-source field.

Compared with Brighthouse as a whole

The same two figures as Brighthouse’s manager page (247,741 ballot items across 83 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsBrighthouseItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)97.9%47476.3%204,500
Backed environmental and social shareholder proposals at US companiesn/a012.8%1,182

Where this fund voted differently from most Brighthouse funds

Each ballot item this fund voted is set against the votes of the other Brighthouse funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most Brighthouse funds on 39 items (7.8% of the 501 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost Brighthouse fundsMgmtResult
JPMorgan Chase & Co.2026-05-19Shareholder Independent board chairmanForABSTAIN or AGAINST — 10 of 15 Brighthouse fundsAgainstNot approved, 35.4% support
Morgan Stanley2026-05-14Shareholder Shareholder proposal requesting an independent Board ChairmanForABSTAIN or AGAINST — 10 of 15 Brighthouse fundsAgainstFailed (calculated), 27.3% support
Wells Fargo & Company2026-04-28Shareholder Shareholder Proposal - Govern by Majority Vote.ForABSTAIN or AGAINST — 10 of 16 Brighthouse fundsAgainstFailed (calculated), 48.3% support
Wells Fargo & Company2026-04-28Shareholder Shareholder Proposal - Request for Board of Directors to Adopt Policy for an Independent Chair.ForABSTAIN or AGAINST — 10 of 16 Brighthouse fundsAgainstFailed (calculated), 34.3% support
Bank of America Corporation2026-05-04Shareholder Shareholder proposal requesting independent board chairForABSTAIN or AGAINST — 8 of 13 Brighthouse fundsAgainstFailed (calculated), 32.6% support
RTX Corporation2026-04-30Election of Directors: George R. OliverForABSTAIN or AGAINST — 8 of 13 Brighthouse fundsForElected, 96.8% support
Citigroup Inc.2026-05-20Proposal to elect 13 Directors: Renee J. JamesForABSTAIN — 6 of 9 Brighthouse fundsForPassed (calculated), 95.2% support
RTX Corporation2026-04-30Advisory Vote to Approve Executive CompensationForABSTAIN or AGAINST — 8 of 14 Brighthouse fundsForApproved, 96.6% support
RTX Corporation2026-04-30Appointment of PricewaterhouseCoopers LLP to Serve as Independent Auditor for 2026ForABSTAIN or AGAINST — 8 of 14 Brighthouse fundsForApproved, 95.3% support
Salesforce, Inc.2026-05-28Approval, on an advisory basis, of the fiscal 2026 compensation of our named executive officers.ForABSTAIN or AGAINST — 9 of 16 Brighthouse fundsForPassed (calculated), 80.8% support
Caterpillar, Inc.2026-06-10Shareholder Shareholder Proposal - Shareholder Right to Act by Written ConsentForABSTAIN or AGAINST — 7 of 12 Brighthouse fundsAgainstNot approved, 39.5% support
The Boeing Company2026-04-17Shareholder Action by Written Consent.ForABSTAIN or AGAINST — 10 of 19 Brighthouse fundsAgainstFailed (calculated), 39.7% support
American Tower Corporation2026-05-20To approve, on an advisory basis, the Company's executive compensation.ForABSTAIN or AGAINST — 6 of 10 Brighthouse fundsForApproved, 94.0% support
RTX Corporation2026-04-30Election of Directors: Bernard A. Harris, Jr.ForABSTAIN — 7 of 13 Brighthouse fundsForElected, 98.8% support
RTX Corporation2026-04-30Election of Directors: Brian C. RogersForABSTAIN — 7 of 13 Brighthouse fundsForElected, 98.7% support
RTX Corporation2026-04-30Election of Directors: Christopher T. CalioForABSTAIN — 7 of 13 Brighthouse fundsForElected, 97.3% support
RTX Corporation2026-04-30Election of Directors: Denise L. RamosForABSTAIN — 7 of 13 Brighthouse fundsForElected, 97.8% support
RTX Corporation2026-04-30Election of Directors: Ellen M. PawlikowskiForABSTAIN — 7 of 13 Brighthouse fundsForElected, 98.9% support
RTX Corporation2026-04-30Election of Directors: Fredric G. ReynoldsForABSTAIN — 7 of 13 Brighthouse fundsForElected, 97.7% support
RTX Corporation2026-04-30Election of Directors: Leanne G. CaretForABSTAIN — 7 of 13 Brighthouse fundsForElected, 98.7% support
RTX Corporation2026-04-30Election of Directors: Robert O. WorkForABSTAIN — 7 of 13 Brighthouse fundsForElected, 93.5% support
RTX Corporation2026-04-30Election of Directors: Tracy A. AtkinsonForABSTAIN — 7 of 13 Brighthouse fundsForElected, 98.2% support
QUALCOMM Incorporated2026-03-17Ratification of the selection of PricewaterhouseCoopers LLP as our independent public accountants for our fiscal year ending September 27, 2026.ForABSTAIN or AGAINST — 7 of 13 Brighthouse fundsForApproved, 92.1% support
Freeport-McMoRan Inc.2026-06-10Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026.ForABSTAIN or AGAINST — 7 of 13 Brighthouse fundsForApproved, 95.7% support
Bristol-Myers Squibb Company2026-05-05Election of Directors: Christopher S. Boerner, Ph.D.ForABSTAIN — 6 of 11 Brighthouse fundsForElected, 95.2% support
Show all 39
Items 26 to 39.
CompanyMeetingItemThis fundMost Brighthouse fundsMgmtResult
Bristol-Myers Squibb Company2026-05-05Election of Directors: Deepak L. Bhatt, M.D., M.P.H., M.B.A.ForABSTAIN — 6 of 11 Brighthouse fundsForElected, 98.9% support
Bristol-Myers Squibb Company2026-05-05Election of Directors: Derica W. RiceForABSTAIN — 6 of 11 Brighthouse fundsForElected, 97.2% support
Bristol-Myers Squibb Company2026-05-05Election of Directors: Julia A. Haller, M.D.ForABSTAIN — 6 of 11 Brighthouse fundsForElected, 98.5% support
Bristol-Myers Squibb Company2026-05-05Election of Directors: Karen H. Vousden, Ph.D.ForABSTAIN — 6 of 11 Brighthouse fundsForElected, 98.9% support
Bristol-Myers Squibb Company2026-05-05Election of Directors: Manuel Hidalgo Medina, M.D., Ph.D.ForABSTAIN — 6 of 11 Brighthouse fundsForElected, 98.5% support
Bristol-Myers Squibb Company2026-05-05Election of Directors: Michael R. McMullenForABSTAIN — 6 of 11 Brighthouse fundsForElected, 99.0% support
Bristol-Myers Squibb Company2026-05-05Election of Directors: Paula A. PriceForABSTAIN — 6 of 11 Brighthouse fundsForElected, 98.1% support
Bristol-Myers Squibb Company2026-05-05Election of Directors: Peter J. ArduiniForABSTAIN — 6 of 11 Brighthouse fundsForElected, 96.9% support
Bristol-Myers Squibb Company2026-05-05Election of Directors: Phyllis R. YaleForABSTAIN — 6 of 11 Brighthouse fundsForElected, 99.4% support
Bristol-Myers Squibb Company2026-05-05Election of Directors: Theodore R. SamuelsForABSTAIN — 6 of 11 Brighthouse fundsForElected, 96.9% support
CVS Health Corporation2026-05-14Shareholder Stockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent.ForAGAINST or ABSTAIN — 5 of 9 Brighthouse fundsAgainst—
Centene Corporation2026-05-12ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION.ForABSTAIN or AGAINST — 4 of 7 Brighthouse fundsForApproved, 91.6% support
Centene Corporation2026-05-12ELECTION OF DIRECTORS: Jessica L. BlumeForABSTAIN or AGAINST — 4 of 7 Brighthouse fundsFor—
Centene Corporation2026-05-12RATIFICATION OF APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2026.ForABSTAIN or AGAINST — 4 of 7 Brighthouse fundsForApproved, 94.6% support

Download all 39 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 97.9% of this fund’s 525 such votes could be given a sector; the other 11 (2.1%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Finance10465.8%
Technology8544.7%
Industrials8045.0%
Health Care6934.3%
Consumer Discretionary4812.1%
Consumer Staples3113.2%
Utilities3000.0%
Energy2514.0%
Telecommunications1516.7%
Real Estate1400.0%
Basic Materials1300.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections3810
Audit-related380
Say-on-Pay360
Corporate Governance2318
Compensation191
Environment or Climate120
Other Social Issues90
Human Rights or Human Capital/workforce30
Shareholder Rights and Defenses32
Capital Structure20

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Centene CorporationMay 12, 2026$14M121
Salesforce, Inc.May 28, 2026$13M181
Marathon Petroleum CorporationApril 29, 2026$12M80
Verizon Communications Inc.May 21, 2026$12M151
CVS Health CorporationMay 14, 2026$12M171
EPAM Systems, Inc.May 21, 2026$12M101
American Tower CorporationMay 20, 2026$12M140
Philip Morris International Inc.May 6, 2026$10M130

Notable votes against management

MeetingCompanyProposalFundMgmt
May 12, 2026Centene CorporationSTOCKHOLDER PROPOSAL REGARDING AN INDEPENDENT BOARD CHAIRMAN. Shareholder proposalAgainstFor
May 28, 2026Salesforce, Inc.A stockholder proposal requesting the adoption of cumulative voting for director elections, if properly presented at the meeting. Shareholder proposalAgainstFor
May 21, 2026Verizon Communications Inc.Independent board chair Shareholder proposalAgainstFor
May 14, 2026CVS Health CorporationStockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent. Shareholder proposalForAgainst
May 21, 2026EPAM Systems, Inc.To hold an advisory vote on a stockholder proposal, entitled "Give Shareholders an Ability to Call for a Special Shareholder Meeting." Shareholder proposalForAgainst
May 14, 2026Morgan StanleyShareholder proposal requesting an independent Board Chairman Shareholder proposalForAgainst
April 29, 2026The AES CorporationIf properly presented, to vote on a non-binding stockholder proposal regarding stockholder ability to call a special meeting. Shareholder proposalForAgainst
May 27, 2026Chevron CorporationAdopt an Independent Chair Shareholder proposalAgainstFor
April 22, 2026The Cigna GroupShareholder Proposal - Shareholder Right to Act by Written Consent Shareholder proposalForAgainst
April 28, 2026Wells Fargo & CompanyShareholder Proposal - Request for Board of Directors to Adopt Policy for an Independent Chair. Shareholder proposalForAgainst
April 28, 2026Wells Fargo & CompanyShareholder Proposal - Govern by Majority Vote. Shareholder proposalForAgainst
May 29, 2026Lowe's Companies, Inc.Shareholder Proposal requesting an independent board chairman. Shareholder proposalAgainstFor

Search this fund’s votes by company

526 ballot items at 36 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, SA Columbia Focused Value Portfolio voted at 36 shareholder meetings of 36 companies, on 526 ballot items in all. Where management made a recommendation, the fund followed it on 91.0% of the items and voted against it 21 times. Its most frequent area of disagreement was corporate governance (18 of its votes against management). It voted on 47 shareholder proposals. It voted FOR the board's own proposals more often than Brighthouse's funds as a whole (97.9% against 76.3%). It voted differently from most Brighthouse funds on 39 items.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Brighthouse’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.